Optimal Two-Stage Designs for Phase II Clinical Trials
Two-stage designs which minimize the maximum sample size are also determined. Optimum and "minimax" designs for a range of design parameters are tabulated. These designs can also be used for pilot studies of new regimens where toxicity is the endpoint of interest. KEY WORDS: clinical trials, phase II trials, optimization ...